{"version":"1.0","type":"link","title":"Immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer patients with preexisting pulmonary emphysema or interstitial lung abnormalities.","author_name":"Chen X 외","author_url":"https://prs-insight.online/author/Chen%20X","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/100996","thumbnail_width":1200,"thumbnail_height":630}